EB Pharma, LLC

Eiger Biopharmaceuticals is a research-driven biopharmaceutical company based in Palo Alto, CA. The company focuses on developing innovative therapies for serious diseases with unmet medical needs. Utilizing cutting-edge technology and scientific expertise, Eiger Biopharmaceuticals is dedicated to advancing novel treatments to improve patient outcomes and quality of life. Generated from their business information

Kodiak Sciences Inc. is a biopharmaceutical company based in Palo Alto, California, dedicated to researching, developing, and commercializing innovative therapies for high-prevalence retinal diseases. The company focuses on addressing significant conditions such as age-related macular degeneration and diabetic retinopathy, aiming to improve the quality of life for millions affected by these conditions. Utilizing its proprietary ABC platform, Kodiak is advancing a pipeline of novel treatments, including bispecific antibody biopolymer conjugates. The company's commitment to scientific excellence is reflected in its ongoing clinical trials and recent positive results, reinforcing its mission to transform the landscape of ocular disease treatment. Generated from the website

Kalaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Palo Alto, California, focused on developing innovative treatments for prevalent retinal diseases. Founded by experienced leaders in ophthalmology, the company aims to address significant unmet needs by creating therapies that ease the burden on patients and caregivers while improving treatment outcomes. The company's lead product, TH103, is a fully humanized recombinant fusion protein designed for intravitreal delivery, demonstrating potential as a best-in-class anti-VEGF agent. With an experienced management team and support from veteran investors, Kalaris is currently evaluating TH103 in a Phase 1 clinical trial for neovascular age-related macular degeneration, with plans to expand its application to other neovascular and exudative retinal diseases. Generated from the website